Anupama Ariyasiri։ A Systematic Review of Transfusion Strategies in Neurocritical Care
Anupama Ariyasiri, Support Lead at ResearchX, Instructor at First Response Initiative of Pakistan, and Secretary General at Surgical Interest Group For Medical Advancements, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Critical Care Research and Practice:
”I’m delighted to share that our article, ‘Liberal Versus Restrictive Blood Transfusion Strategies in Neurocritical Care: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,’ has been published in Critical Care Research and Practice. (Jan 2026)
Grateful to be a co-author on this publication and thankful to all the collaborators involved. Special appreciation to Ayesha Shaukat for her dedication and valuable contributions to the project.”
Title: Liberal Versus Restrictive Blood Transfusion Strategies in Neurocritical Care: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Authors: Ayesha Shaukat, Muhammad Ahmed Zahoor, Komal Khan, Aiman Shahid Khan, Rubaisha Saleem, Anupama Ariyasiri, Syed Abdul Aziz Jameel, Shahab Afridi, Syeda Javeria Salman, Noor Naeem, Marib Ashraf, Amamah Rauf Chaudhry, Zobia Ahmad, Muhammad Omar Larik, Muhammad Hasanain, Muhammad Umair Anjum, Aymar Akilimali
Read the Full Article on Critical Care Research and Practice
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 13, 2026, 10:08Jack Hadfield: An Important Step Toward Finding Measurable Biology in Long COVID
-
Mar 13, 2026, 10:00Mandy Lauw: Can Reduced-Dose DOACs Be Applied to All Patients With VTE?
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis